This three-day international symposium is the third RAS community-wide meeting sponsored by the NCI RAS Initiative.
The overarching goal of the NCI RAS Initiative is to mobilize the cancer research community to develop ways to understand and target cancers driven by mutant RAS in an open model of collaboration among government, academic, and industry researchers.
The Symposium will feature invited presentations, short presentations from selected abstracts, and poster presentations. Session topics will include RAS Biology, RAF Structure, RAS in Membranes, RAS Synthetic Lethalities, Drug Development, and Rasopathies.